Vilanterol

75 interactions 5 explained in plain English

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Hydroxychloroquine Ivabradine Penbutolol Bisoprolol Amisulpride Injection Ofloxacin Otic

74 Major 1 Moderate

All (75) Major (74) Moderate (1)

Major

Vilanterol Amitriptyline Elavil Explained Increased risk of cardiovascular adverse effects and an increased risk of QT interval prolongation Details Vilanterol Sertraline Explained An increased risk of QT interval prolongation Details Vilanterol Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Vilanterol Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Vilanterol Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Vilanterol Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Vilanterol Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Vilanterol Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Vilanterol Asenapine Transdermal Patch Secuado An increased risk of QT interval prolongation Details Vilanterol Atenolol Tenormin Explained Decreased efficacy of vilanterol Details Vilanterol Azithromycin AzaSite An increased risk of QT interval prolongation Details Vilanterol Acebutolol Sectral® Decreased efficacy of vilanterol Details Vilanterol Alfuzosin UroXatral An increased risk of QT interval prolongation Details Vilanterol Anagrelide Agrylin Increased risk of QT interval prolongation Details Vilanterol Bedaquiline Sirturo An increased risk of QT interval prolongation Details Vilanterol Betaxolol Betoptic S Decreased efficacy of vilanterol Details Vilanterol Betaxolol Ophthalmic Betoptic® Decreased efficacy of vilanterol Details Vilanterol Bisoprolol Zebeta® Decreased efficacy of vilanterol Details Vilanterol Chloroquine Aralen® Increased risk of QT-interval prolongation Details Vilanterol Dasatinib Phyrago An increased risk of QT interval prolongation Details Vilanterol Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Vilanterol Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Vilanterol Disopyramide Norpace An increased risk of QT interval prolongation Details Vilanterol Dofetilide Tikosyn An increased risk of QT interval prolongation Details Vilanterol Dolasetron Anzemet An increased risk of QT interval prolongation Details Vilanterol Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Vilanterol Encorafenib Braftovi Increased risk of QT interval prolongation Details Vilanterol Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Vilanterol Eribulin Injection Halaven An increased risk of QT interval prolongation Details Vilanterol Esmolol Brevibloc Decreased efficacy of vilanterol Details Vilanterol Famotidine Calmicid An increased risk of QT interval prolongation Details Vilanterol Famotidine Injection Calmicid An increased risk of QT interval prolongation Details Vilanterol Felbamate Felbatol An increased risk of QT interval prolongation Details Vilanterol Flecainide Tambocor® An increased risk of QT interval prolongation Details Vilanterol Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Vilanterol Fostemsavir Rukobia Increased risk of torsade de pointes Details Vilanterol Galantamine Razadyne An increased risk of QT interval prolongation Details Vilanterol Gatifloxacin Ophthalmic Zymar® An increased risk of QT interval prolongation Details Vilanterol Gemifloxacin Factive An increased risk of QT interval prolongation Details Vilanterol Glasdegib Daurismo Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.